Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD

NCT: NCT06324448 · COMPLETED

NCT IDNCT06324448

StatusCOMPLETED

Start Date2024-02-15

Completion2026-02-24

Brief Summary

The purpose of this study is to investigate the efficacy and safety of self-administered transcranial direct current stimulation to improve the single- and dual-task gait in patients with Parkinson's disease.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑